Role of anti-mutated citrullinated vimentin antibodies in chronic hepatitis C patients and its relation to HCV associated arthritis

Role of anti-mutated citrullinated vimentin antibodies in chronic hepatitis C patients and its relation to HCV associated arthritis

Aim of the work: To determine the frequency of anti-mutated citrullinated vimentin (anti-MCV) antibodies in chronic hepatitis C virus (HCV) patients and its relation to HCV associated arthritis. Patients and methods: The study included 60 HCV patients and 30 age and sex matched control. Patients wer...

Full description

Bibliographic Details
Main Authors:	Shahira El Fedawy, Hala Ghareeb, Neama Lotfy, Noran Osama El-Azizi, Asmaa Mahmoud
Format:	Article
Language:	English
Published:	Elsevier 2017-07-01
Series:	Egyptian Rheumatologist
Subjects:	Anti-mutated citrullinated vimentin antibody (anti-MCV) HCV infection Arthritis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1110116416300862

Similar Items

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
by: Somayye Norouzi, et al.
Published: (2020-08-01)

Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis
by: Ishigooka, Nozomi
Published: (2020)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
by: Alireza Sadeghi, et al.
Published: (2017-04-01)

Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
by: Refaat M El Tanawy, et al.
Published: (2015-01-01)

Features of Clinical and Laboratory Parameters in Children with Arthritis, which Have Increased Antibody Titers to Cyclic Citrullinated Peptide and Modified Citrullinated Vimentin
by: I.S. Lebets, et al.
Published: (2013-03-01)

Antibodies against post-translationally modified vimentin peptides in patients with rheumatoid arthritis
by: P. A. Kuznetsova, et al.
Published: (2017-09-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
by: Nicole H. Trier, et al.
Published: (2019-06-01)

Methotrexate-induced changes in the concentration of antibodies to modified citrulnated vimentin in blood serum of patients with rheumatoid arthritis
by: Natal'ya Petrovna Shilkina, et al.
Published: (2011-05-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

Evaluation of disease activity markers in relation to dry eye disease in patients with rheumatoid arthritis
by: Mohja A El-Badawy, et al.
Published: (2017-01-01)

Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study
by: Pit Hui Lew, et al.
Published: (2021-07-01)

Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
by: Irene Ramos, et al.
Published: (2020-06-01)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
by: Nicole H. Trier, et al.
Published: (2017-03-01)

Antibodies to Citrullinated Proteins (ACPA) Associate with Markers of Osteoclast Activation and Bone Destruction in the Bone Marrow of Patients with Rheumatoid Arthritis
by: Weronika Kurowska, et al.
Published: (2021-04-01)

Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition
by: Ilaria Fanelli, et al.
Published: (2021-07-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
by: Hisakata Yamada, et al.
Published: (2020-04-01)

Are antibodies to fine specificities of citrullinated peptides/proteins useful for stratification of rheumatoid arthritis patients?
by: Leonor Nogueira, et al.
Published: (2021-01-01)

Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis
by: Chao-Yi Wu, et al.
Published: (2020-06-01)

CHARACTERISTICS OF AUTOIMMUNE INFLAMMATION IN THE PATIENTS WITH LUNG TUBERCULOSIS
by: A. A. Starshinova, et al.
Published: (2019-12-01)

Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis
by: Alessandra Zaccardelli, et al.
Published: (2019-11-01)

Synovial fluid anti-citrulline-containing peptide antibody and its role in the diagnosis of rheumatoid arthritis
by: Ali I Fouda, et al.
Published: (2017-01-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity
by: Cui, J., et al.
Published: (2022)

Phenylglyoxal-Based Visualization of Citrullinated Proteins on Western Blots
by: Sanne M. M. Hensen, et al.
Published: (2015-04-01)

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
by: Wei-Ming Chen, et al.
Published: (2021-05-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies, adenosine deaminase activity and other potential biomarkers for predicting and monitoring rheumatoid arthritis
by: Mehanović-Nikolić Jasminka, et al.
Published: (2008-01-01)

Early Diagnosing and Treatment of Rheumatoid Arthritis, Benefits of Anti-Citrullinated Peptides Examination
by: Belakova Gabriela, et al.
Published: (2017-08-01)

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
by: Chao-Yi Wu, et al.
Published: (2021-01-01)

DIAGNOSTIC VALUE OF ANTI-PEPTIDYLARGININE DEIMINASE TYPE 4 (PADI-4) AND ANTI- CITRULLINATED PEPTIDE ANTIBODIES (ACCP) IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS
by: Hassan J Hasony, et al.
Published: (2014-06-01)

Detection of Viral Citrullinated Peptide Antibodies Directed Against EBV or VCP: In Early Rheumatoid Arthritis Patients of Indian Origin
by: Sudha S Deo, et al.
Published: (2010-07-01)

Is anti-cyclic citrullinated peptide antibody a good value biomarker for alzheimer disease?
by: Rokhsareh Meamar, et al.
Published: (2013-01-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2012-02-01)

Comparative studies in detection of anti-HCV antibodies using Abbott IMx HCV, Serodia-HCV and DETECT-HCVTM
by: Nisarat Apichartpiyakul, et al.
Published: (2010-01-01)

Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis
by: Monika Gudowska, et al.

Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort
by: Ingiäld Hafström, et al.
Published: (2019-02-01)

The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis
by: Stamenković Bojana, et al.
Published: (2012-01-01)

Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort
by: Koichi Murata, et al.
Published: (2020-11-01)

The Contribution of Serum Anti–cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 in Predicting the Activity of Rheumatoid Arthritis Disease
by: Aida R. Al-Derzi
Published: (2017-07-01)

Cannot write session to /tmp/vufind_sessions/sess_g6vfnjs6p16f19uh5kc8avq6sf